Menu Close
Training

CDA Foundation provides training to ministries of health, medical professionals, and public health professionals for hepatitis C and hepatitis B disease burden and economic impact modeling.

The trainings are free of charge and last 1–2 weeks depending on the scope (HBV, HCV, disease burden, economic impact). The training is conducted at our office in Lafayette, Colorado unless there are enough people to justify traveling to a country. CDA Foundation provides invitation letters and support for a visa.

2015

Reference Center for Viral Hepatitis, Central Research Institute of Epidemiology, Russia — Drs. Vladimir Chulanov, Alexandar Urtikov

2016

University of New South Wales, Australia — Dr. Amy Kwon

National Liver Institute, Menoufia University, Egypt — Drs. Sameera Ezzat, Ayat Abdullah

University of Athens, Greece — Dr. Ilias Gkountas

2017

University of Zurich, Switzerland — Dr. Urs Rusch

World Health Organization, Western Pacific Office, Philippines — conducted for a large group in Manila

  • China — Drs. Shaodong Ye, Hui Zheng
  • Cambodia — Drs. Bun Sreng, Deng Serongkea
  • Fiji
  • Kiribati
  • Laos — Dr. Philavanh Sitbounlang
  • Malaysia — Dr. Fazidah Binti Yusman
  • Mongolia — Dr. Erdenetsogt Naran-Ochir, Narantuya Jadambaa
  • Papua New Guinea — Drs. Anup Gurung, Mathias Bauri
  • Philippines — Drs. Hilton Lam, Justina Zapanta
  • Republic of Korea
  • Vietnam — Drs. Tran Dai Quang, Nguyen Thi Thuy Van
  • WPRO — Drs. Linh-Vi Le, Joseph Woodring, Po-Lin Chan
  • WHO — Dr. Yvan Hutin

Ministry of Health, Department of HIV/AIDS, Tuberculosis, Viral Hepatitis and Sexually Transmitted Infections, Brazil — conducted for a large group in Brasília

Italian National Institute of Health, National Centre for Global Health, Italy — Dr. Loreta Kondili

2018

Tor Vergata University of Rome, Italy — conduced for a large group in Rome

2019

National Liver Institute, Menoufia University, Egypt — conducted for a large group in Cairo (Drs. Sahar Khalil Kandil, Alshaimaa Mohamed Abdelmoaty Abouelella, Hanan Mosleh Ibrahim, Randa Eldessouki, Eman Eltahlawy , Noha Muhammad el Qareh, Tarek Abd Elaziz, Wesam Saber Morad, Ghada Nasr Radwan, Eman Hany Ahmed Elsebaie)

Division of Epidemiology, Dalla Lana School of Public Health, Faculty of Medicine, University of Toronto, Canada — Dr. Hla Hla (Rosie) Thein

2020

National Liver Institute, Menoufia University, Egypt — Drs. Sameera Ezzat, Ayat Roushdy, Alaa Osman

International Cooperation and Development Fund, Taiwan — Dr. Doris Lin

2021

Jilin University/ China CDC, China — Dr. Shaodong Ye

2022

Research Institute of Virology, Uzbekistan — Drs. Shakhlo Sadirova, Komiljon Khamzayev

New Zealand Ministry of Health, New Zealand — Dr. James Greenwell

Brazil Ministry of Health, Department of HIV/AIDS, Tuberculosis, Viral Hepatitis and Sexually Transmitted Infections, Brazil — conducted for a large group in Brasília (Aline Almeida da Silva, Ana Paula Maciel Gurski, Beatriz Brittes Kaminski, Carlos Alberto de Albuquerque Almeida Junior, Everton Macedo Silva, Guilherme Borges Dias, Ivan Zimmermann, Karen Cristine Tonini, Loraine Melissa Dal-Ri, Nazle Mendonça Collaço Véras, Patricia Carla dos Santos, Paula Pezzuto, Rayane Martins da Silva, Rogger Diquique, Romina do Socorro Marques de Oliveira, Samara Carolina Rodrigues, Sebastião Bruno Taveira da Silva, Tiago Benoliel Rocha)

en_USEnglish